From Patient to Participant: Understanding Chemo Brain Through Research

From Patient to Participant: Understanding Chemo Brain Through Research

From Patient to Participant: Understanding Chemo Brain Through Research A patient with cancer reflects on participating in a clinical study and how community and creativity helped ease chemo brain symptoms. I was a participant in a clinical study on Chemo Brain conducted by the Eastman Performing Arts Medicine Center in […]

Read More
Urgent Appeal: Young People Needed to Save Lives

Urgent Appeal: Young People Needed to Save Lives

Appeal for more young people to step forward as stem cell donors to save lives An urgent appeal was made in the UK Parliament for more young people to join the stem cell donor register because for many patients with blood cancers or rare blood disorders, finding a match is […]

Read More
Hope in the fight against blood cancer

Hope in the fight against blood cancer

Hope in the fight against blood cancer Johnson & Johnson has received FDA (food and drug administration federal agency) approval for a new treatment option for adults newly diagnosed with multiple myeloma who are not eligible for an autologous stem cell transplant in the United State. The treatment, Darzalex Faspro, […]

Read More
Clinical breakthrough: Manchester Royal Infirmary delivers UK first NHS treatment to a patient with an aggressive blood cancer

Clinical breakthrough: Manchester Royal Infirmary delivers UK first NHS treatment to a patient with an aggressive blood cancer

A 28-year-old patient with acute lymphoblastic leukaemia, has become the first patient in the UK to be treated on the NHS with an innovative personalised therapy at Manchester Royal Infirmary.  https://www.youtube.com/watch?v=dvOmDOzsHN0&t=19s The CAR-T treatment, known as obe-cel, has been developed, researched, and manufactured in the UK and specialists at Manchester […]

Read More
New research aims to transform treatments of aggressive blood cancer

New research aims to transform treatments of aggressive blood cancer

A new study involving researchers from the University of York is set to transform treatments for one of the most aggressive and hard-to-treat blood cancers – acute myeloid leukaemia (AML). If successful, the research could significantly improve the lives of patients by offering gentler, more effective treatments that reduce suffering […]

Read More
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.